Evolent Health (EVH) Current Deferred Revenue (2015 - 2026)

Evolent Health has reported Current Deferred Revenue for 12 years, with the latest figure at $1.2 million in Q2 2026.

• On a quarterly basis, Current Deferred Revenue fell 54.64% year-over-year to $1.2 million in Q2 2026; TTM through Jun 2026 was $1.2 million, a 54.64% decrease from a year earlier, with the FY2025 full-year figure at $1.3 million, down 47.63% from the prior year.
• Current Deferred Revenue was $1.2 million for Q2 2026 at Evolent Health, down from $1.4 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $17.3 million in Q1 2022, with the low at $1.2 million in Q2 2026.
• Average Current Deferred Revenue over 5 years is $6.2 million, with a median of $6.1 million recorded in 2024.
• The sharpest annual moves came in 2022 and 2026: Current Deferred Revenue dropped 7.85% in 2022, then sank 71.76% in 2026.
• Over 5 years, Current Deferred Revenue stood at $8.3 million in 2022, then dropped by 13.77% to $7.1 million in 2023, then plunged by 64.93% to $2.5 million in 2024, then sank by 47.63% to $1.3 million in 2025, then retreated by 8.0% to $1.2 million in 2026.
• The last three Current Deferred Revenue figures came in at $1.2 million (Q2 2026), $1.4 million (Q1 2026), and $1.3 million (Q4 2025), per Business Quant data.